Request Demo
Last update 01 Jul 2026
LUCAR-G79
Last update 01 Jul 2026
Overview
Basic Info
Drug Type γ-δT, Universal CAR-T |
Synonyms LB-2404D, LB2404D, LUCAR-G79 + [1] |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD70 inhibitors(CD70 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with LUCAR-G79NCT07331272
An Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
NCT07049081
An Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases (r/r AID)
100 Clinical Results associated with LUCAR-G79
Login to view more data
100 Translational Medicine associated with LUCAR-G79
Login to view more data
100 Patents (Medical) associated with LUCAR-G79
Login to view more data
100 Deals associated with LUCAR-G79
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 | China | 17 Jul 2025 | |
| Idiopathic Inflammatory Myopathies | Phase 1 | China | 17 Jul 2025 | |
| Immunoglobulin G4-Related Disease | Phase 1 | China | 17 Jul 2025 | |
| Systemic Lupus Erythematosus | Phase 1 | China | 17 Jul 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free